Latest News about psychedelics
Recent news which mentions psychedelics
High Tide Closes Final Tranche Of $15M Debt, Plans Retail Growth
November 13, 2024
From Benzinga
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
From Benzinga
DEA Faces Lawsuit Alleging Bias In Marijuana Rescheduling Process
November 12, 2024
From Benzinga
Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments
November 12, 2024
Tickers
NEWS
From Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
From Benzinga
From Benzinga
U.S. Election Stress Fuels Demand For Psychedelic-Assisted Therapy
November 11, 2024
From Benzinga
Psychedelic Mushrooms Market Poised For $3.3 Billion Surge By 2031
November 11, 2024
Tickers
NEWS
From Benzinga
Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing
November 11, 2024
From Benzinga
UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis
November 07, 2024
From Benzinga
Could Trump's 'Go Wild On Health' Invite To RFK Jr. Drive Changes For Cannabis And Psychedelics?
November 07, 2024
Tickers
NEWS
From Benzinga
California College Launches Nation's First Psychedelic Studies Degree For Undergraduates
November 07, 2024
Tickers
NEWS
From Benzinga
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
November 07, 2024
From Benzinga
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
November 06, 2024
From Benzinga
Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?
November 06, 2024
Tickers
NEWS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.